1-11 of 11
Keyword: Parkinson's disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2016) 130 (8): 565–574.
Published: 08 March 2016
... degeneration include Menkes disease and Wilson's disease but a large body of evidence also implicates disrupted copper pathways in other neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, Huntington's disease and prion diseases. In this short review...
Articles
Clin Sci (Lond) (2015) 129 (8): 757–767.
Published: 29 July 2015
... mice. SP failed to interfere with microglial proliferation but induced migration through a NK1R /protein kinase Cδ (PKCδ)/NADPH oxidase (NOX2) pathway-dependent manner. chemotaxis microglia distribution Parkinson's disease • We have reported that SP potentiates microglial activation...
Articles
Clin Sci (Lond) (2011) 120 (10): 427–440.
Published: 28 January 2011
... permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. aging Alzheimer's disease atherosclerosis heart failure longevity Parkinson's disease telomerase telomere The 2009 Nobel Prize in Physiology or Medicine...
Articles
Clin Sci (Lond) (2006) 110 (3): 369–377.
Published: 10 February 2006
... patients with Parkinson's disease (PD) with Hoehn and Yahr stages 1–4. Patients were investigated once with their regular treatment and once after 12 h of interruption of L -dopa treatment. L -Dopa intake significantly reduced systolic and diastolic blood pressure, heart rate and plasma noradrenaline and...
Articles
Clin Sci (Lond) (2005) 109 (4): 355–364.
Published: 23 September 2005
...Shushant Jain; Nicholas W. Wood; Daniel G. Healy Major progress has been made in the last decade in understanding the genetic basis of PD (Parkinson's disease) with five genes unequivocally associated with disease. As a result, multiple pathways have been implicated in the pathogenesis of PD...
Articles
Clin Sci (Lond) (2005) 109 (4): 343–354.
Published: 23 September 2005
... the diagnosis and management is emphasized. Correspondence: Dr Bradley F. Boeve (email bboeve@mayo.edu ). 17 3 2005 13 4 2005 The Biochemical Society 2005 dementia with Lewy bodies (DLB) genetic basis Lewy body disease Parkinson's disease Friederich Lewy in...
Articles
Clin Sci (Lond) (1994) 86 (2): 149–158.
Published: 01 February 1994
... concentration was not closely linked either pharmacologically or biochemically to central noradrenergic neuronal activity. 4. Cerebrospinal fluid dopamine β-hydroxylase was not changed in essential hypertension. In Parkinson's disease, cerebrospinal fluid dopamine β-hydroxylase was markedly diminished (16.3...
Articles
Clin Sci (Lond) (1992) 83 (2): 199–204.
Published: 01 August 1992
...H. S. Markus; M. Cox; A. M. Tomkins 1. Resting energy expenditure was measured, by indirect calorimetry, in 12 patients with Parkinson's disease and in eight healthy age-matched control subjects. In the patients with Parkinson's disease measurements were made in both the untreated state and after...
Articles
Clin Sci (Lond) (1979) 56 (1): 89–93.
Published: 01 January 1979
...D. A. Bender; C. J. Earl; A. J. Lees 1. Benserazide and carbidopa, decarboxylase inhibitors used in the treatment of Parkinson's disease, have been shown to inhibit the enzyme kynurenine hydrolase in rat and mouse liver. This results in reduced synthesis of nicotinamide coenzymes from tryptophan...
Articles
Clin Sci Mol Med (1977) 53 (4): 321–328.
Published: 01 October 1977
...C. S. Wilcox; M. J. Aminoff; J. D. H. Slater 1. The renal excretion of sodium by five patients with autonomic failure (Shy—Drager syndrome) was compared with a matched control group who had normal autonomic reflexes (Parkinson's disease). For 8 or 9 days the daily sodium intake was reduced to 17...
Articles
Clin Sci Mol Med (1974) 46 (4): 481–488.
Published: 01 April 1974
...C. S. Wilcox; M. J. Aminoff; A. B. Kurtz; J. D. H. Slater 1. The effect on plasma renin activity (PRA) of dopamine and noradrenaline infusions was studied in three patients with Shy—Drager syndrome, three patients with Parkinson's disease and normal autonomic reflexes, and three healthy volunteers...